The Calver Chronicle

Published 05:00 GMT+0 · 93 stories

Markets

Market Daily Brief: HSBC earns more, and the market sells it anyway

How we score a company →

Market Daily Brief

By Arthur Ledger: Sunday editorials and daily company notes

Tuesday was a lesson in how markets weigh good news against worry. HSBC reported a strong quarter and fell about 6%. Reckitt trimmed its sales forecast and slipped 4%. Brazil had its worst day in a generation. The patient owner's job is to separate what a business earns from what the crowd fears this week.

Brazil, the Budget and oil

Brazil's real fell 8%, its worst day since 1999, and the Bovespa dropped 13.9% after Lula's re-election. The deficit is 9.5% of GDP, debt 83% and the Selic rate 13.75%. At home, Chancellor John Healey delivers the Budget on Wednesday, promising "everyday fixes" rather than giveaways. The Joseph Rowntree Foundation says family incomes will be £440 to £770 lower this parliament. A First Time Buyer ISA is set to replace the Lifetime ISA, alongside a "My First Home" equity loan and possible energy bill relief, with UK gas above 200p a therm and Brent near $115.65.

Elsewhere, the Nasdaq 100 rose 1.1% on Monday after Anthropic's listing filing showed revenue above $33bn in the nine months to September, about $800bn of computing commitments, five customers making up a quarter of revenue and founders holding 50.1% of the votes. Korea's Kospi rose 3%. An opinion piece from UBS HOLT argues UK shares are the cheapest in the G10 on free cash flow, with UK financials at their widest discount to European peers in 30 years.

What our checks found

HSBC: 10/20. Pre-tax profit rose 32% to $9.6bn, but $1.4bn of that is simply last year's legal charge not repeating. Strip that out and it earns about 18% on tangible equity, trades near 10 times earnings and yields about 5%. But at about 1.8 times tangible book, with a sprawling balance sheet, Hong Kong property losses and a possible bank-tax rise on Wednesday, the price leaves little room for error.

Reckitt: 12/20. Dettol, Durex and Finish are fine brands, and prices are still rising. But a Lysol supply problem in its biggest market, a cut to sales guidance and weak cash conversion this year leave it at about 17 times earnings with debt at 2.5 times profit. We stripped out the loss on selling its Russian hygiene business.

Sanofi: 11/20. Cheap at about 9.5 times its own earnings measure, with an 8% cash yield. But Dupixent is over a third of sales and loses US patent protection early next decade, the pipeline has stumbled and a new chief executive, Belén Garijo, is only six months in. Results come Friday.

Microsoft: 11/20. A wonderful franchise, but at about 32 times earnings, once investment gains are stripped out, and with free cash flow down 23% last quarter as spending heads for $175bn, there is no margin of safety. Results come Wednesday.

Nidec: 4/20, too hard. Its auditor refused to sign the accounts even after ¥632bn of write-downs, and the company is suing its founder. We cannot value a business whose numbers we cannot trust.

Unchanged: Meta 10, ASML 13 and Tesla 6 (too hard).

Mention only

- EQT, the buyout firm, has agreed a €46.50 a share cash bid for Qiagen. Anthropic plans to list next month; it is not yet trading.
- The Bank of England has ordered a review of Revolut's controls, and DWS is paying out only 10% of redemption requests at its flagship property fund.
- America's Fed is set to stick with quarterly rate rises.

Also on our desk (since Monday's article)

- Intuitive Surgical 15/20 (Monday X sweep): a superb, debt-free robotics franchise, but at about 48 times adjusted earnings it needs a price nearer $300.
- Fair Isaac 12/20: the cheapest in years, but holding prices this year weakens its moat and the balance sheet is stretched.
- Teleperformance 8/20 and Concentrix 6/20 (too hard): cheap on cash flow, but AI threatens call-centre work and Concentrix carries heavy debt.
- Nu Holdings fell 20% in the Brazil sell-off; we scored it 10 earlier and have not rescored it.

Nothing new cleared 15 today. Good results and a falling price can arrive on the same morning. We would rather buy a fine business at a fair price than a cheap one we cannot understand.

Research only, not investment advice.

Markets: FTSE 100 and Wall Street close higher as Anthropic filing lifts AI stocks

• FTSE 100 (Monday close): 10,767.33, up 76.97 points or 0.72%; FTSE 250 up 1.1% at 24,501.25.
• Dow Jones (Monday close): 52,361.58, up 146.42 or 0.28%.
• S&P 500 (Monday close): 7,676.77, up 53.09 or 0.70%; Nasdaq Composite 26,169.38, up 214.04 or 0.82%.
• GBP/USD (early Tuesday, overnight trading): about $1.334, after closing Monday near $1.334-$1.338 depending on the source.

London's blue-chip index rose on Monday, its biggest one-day gain since 15 October, as Anthropic's filing for a US share listing lifted sentiment towards artificial intelligence stocks and investors looked ahead to Wednesday's Budget and the US Federal Reserve's policy decision. Banking and defence shares were among the gainers, according to Sharecast. The FTSE 250 had its largest daily rise since 9 October. On Wall Street, chipmakers rallied and all three main indexes closed higher. Figures are Monday closing levels reported by Reuters and Dow Jones Market Data, checked against AJ Bell and CNBC. Sterling was little changed in overnight trading.

Photo: gren, public domain, via Wikimedia Commons (Paternoster Square, home of the London Stock Exchange; file photo)
Source: Reuters; Dow Jones Market Data; AJ Bell; CNBC; Yahoo Finance. Linked: Morningstar (Dow Jones).

Anthropic files for Nasdaq listing, disclosing $16.3bn half-year revenue

• The Claude developer plans to list on the Nasdaq under the symbol ANT.
• It reported revenue of $16.3bn in the first half of the year; the BBC put losses at more than $80.7bn and CNBC at over $80bn.
• The number of shares, price range and listing date have not been disclosed.
• Its filing warns advanced AI could pose "catastrophic or existential risks to humanity" without safeguards.

Anthropic has published its filing for a stock market flotation in the United States, giving investors their first detailed look at the finances of one of the largest artificial intelligence developers. The company, which makes the Claude chatbot, said it would list on the Nasdaq and reported sharply higher revenue alongside heavy losses driven by spending on computing power. The filing also set out unusual risk factors, including the possibility that AI systems could cause serious harm, and said a hacking group it believed to be sponsored by China had manipulated Claude to break into several institutions. Pricing and timing will be set later.

Source: BBC; NPR; CNBC; DW; Sky News. Linked: NPR.

Microsoft offers voluntary buyouts to about 60,000 staff, including in UK

• Microsoft is offering voluntary redundancy packages to about 60,000 employees, roughly a quarter of its workforce.
• The offer covers staff in the US, Canada, India and the UK, according to reports.
• The company is increasing investment in artificial intelligence.
• Microsoft had about 223,000 employees worldwide.

Microsoft is offering voluntary buyouts to around 60,000 employees, about one in four of its global workforce, as it shifts spending towards artificial intelligence. CBS News and CNBC reported the scale of the offer, and Sky News said it included workers in the UK. The company has invested heavily in data centres and AI chips and has cut thousands of jobs over the past two years. Staff who accept will receive severance packages; Microsoft has not said how many departures it expects. The Associated Press and Reuters also reported the move, which was announced on Monday.

Photo: Jiaqian AirplaneFan, CC BY 3.0, via Wikimedia Commons (Microsoft campus, Redmond; file photo)
Source: CNBC; CBS News; Sky News; Associated Press. Linked: CNBC.